Medical Device Outsourcing Market to Reach Valuation of USD 347.63 Billion by 2030 – The Rising Demand for Medical Devices, Intensifying Price Competition, and the Need to Curtail Costs Drives the Market

Vantage Market Research

Feb 18, 2024

In terms of revenue, the Global Medical Device Outsourcing Market is expected to reach by 2030, growing at a CAGR (Compound Annual Growth Rate) of 11.57% from 2023 to 2030.

The Medical Device Outsourcing market is undergoing a significant transformation fueled by a convergence of factors shaping the industry's trajectory. This overview establishes the context for comprehending the various factors in motion, ranging from the growing need for medical devices to the necessity of cost reduction and the evolving clinical trial landscape in the post-pandemic era. The primary factors for market development are the rising demand for medical devices, intensifying price competition, and the need to curtail costs. This scenario compels companies to embrace outsourcing as a strategic solution. Alongside, growing complexities in product engineering and the arrival of new market entrants are steering the industry toward increased innovation. The demand for novel technologies and patient-friendly devices fosters a dynamic environment, enhancing the overall pipeline of medical devices. 

Key Highlights from the Report

  • Based on the segmentation of Service, the Contract Manufacturing segment dominates the Medical Device Outsourcing market with 52% of revenue share. This is attributed to the escalating complexity of manufacturing. The focus on producing more high-quality and safe devices for patient care poses a significant challenge for medical device manufacturers. The stringent inspection requirements in the development of medical devices have resulted in many standards and regulations, fostering a demand for contract manufacturing services.
  • Furthermore, based on the Application segmentation, the Cardiology segment is responsible for most of the market growth, i.e., 20.1% of market share in 2022, because of the increasing occurrence of cardiovascular disorders like rheumatic heart disease, myocardial infarction, angina pectoris, hypertensive heart disease, atrial fibrillation, and congenital heart disease. The rise in surgical procedures further contributes to this dominance. Also, the substantial complexities associated with cardiovascular devices, the growing demand for technical expertise, and the high production costs for such products can lead original equipment manufacturers (OEMs) to opt for increased outsourcing.
  • Finally, based on the Region, the Asia Pacific region is the leading force in the Medical Device Outsourcing market, driven by growing demand due to chronic diseases, supported by the presence of key companies and competitive pricing. 

Market Dynamics

The increasing inclination towards outsourcing manufacturing operations has become imperative, aiming to reduce direct costs and modernize supply chains while addressing the challenge of escalating operating expenses. Currently, various factors are driving the expansion of the contract manufacturing sector. Intense competition has compelled device manufacturers to concentrate on their fundamental strengths in research and development, marketing, clinical education, and sales. Medical Device Outsourcing offers both cost savings and improved service delivery. 

Moreover, the stringent regulatory landscape, governed by entities like the FDA and EMA, is pivotal in shaping outsourcing decisions within medical device companies. Outsourcing emerges as a positive influencer on market growth by ensuring compliance with regulatory norms throughout the product development lifecycle.

The global perspective on medical device demand reveals a highly competitive industry driven by factors like population aging, growth in emerging countries, and rising GDP. Despite the high demand, challenges persist due to a shortage of medical professionals, necessitating advanced devices for early diagnosis and minimally invasive treatment. Established firms strategically outsource various business activities, indicating a promising market projected to grow significantly during the forecast period. Challenges such as increasing competitiveness, dual-pricing trajectories, and industry consolidation through M&A activities are reshaping the competitive landscape. As the industry evolves, globalization and strategic outsourcing trends will continue, emphasizing mitigating operational risks and ensuring swift time-to-market for medical devices.

The Asia Pacific region dominates the Medical Device Outsourcing market and is expected to maintain its significant influence throughout the forecast period. The growing incidence of chronic disorders, leading to an accelerated demand for medical devices, is a significant driver for market increase in this region. 

Additionally, the presence of key companies and competitive pricing further contribute to the factors expected to propel the market in this geographical area. 

The Global Medical Device Outsourcing Market is Segmented as follows

  • Service
    • Regulatory Affairs Services
    • Product Design and Development Services
    • Contract Manufacturing
    • Quality Assurance
    • Product Upgrade Services
    • Product Testing & Sterilization Services
    • Product Implementation Services
    • Product Maintenance Services
  • Application
    • Cardiology
    • Orthopedic
    • Ophthalmic
    • IVD
    • Diagnostic Imaging
    • Drug Delivery
    • Dental
    • Endoscopy
    • Diabetes Care
    • General and Plastic Surgery
    • Other Applications
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
 

List of the Key Players of the Global Medical Device Outsourcing Market is

Eurofins Scientific (Luxembourg), Integer Holdings Corporation (U.S.), Pace Analytical Services LLC (U.S.), Intertek Group PLC (UK), Plexus Corp. (U.S.), IQVIA Inc. (U.S.), North American Science Associates LLC (U.S.), Charles River Laboratories (U.S.), West Pharmaceutical Services Inc. (U.S.), WuXi AppTec (China), TE Connectivity (Switzerland), Freyr Solutions (Singapore) 

The Global Medical Device Outsourcing Market Scope can be Tabulated as below

Parameter Details
Market Size Provided for Years 2018 - 2032
Base Year 2023
Historic Years 2018 - 2022
Forecast Years 2024 - 2032
Segments Covered
  • Service
    • Regulatory Affairs Services
    • Product Design and Development Services
    • Contract Manufacturing
    • Quality Assurance
    • Product Upgrade Services
    • Product Testing & Sterilization Services
    • Product Implementation Services
    • Product Maintenance Services
  • Application
    • Cardiology
    • Orthopedic
    • Ophthalmic
    • IVD
    • Diagnostic Imaging
    • Drug Delivery
    • Dental
    • Endoscopy
    • Diabetes Care
    • General and Plastic Surgery
    • Other Applications
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
Regions & Counties Covered
  • North America
    • U.S.
    • Canada
    • Mexic
  • Eurpe
    • U.K
    • France
    • Germany
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Suth Korea
    • South East Asia
    • Rest Of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest Of Latin America
  • Middle East & Africa
    • GCC Cuntries
    • South Africa
    • Rest Of Middle East & Africa
Companies Covered
  • Eurofins Scientific (Luxembourg)
  • Integer Holdings Corporation (U.S.)
  • Pace Analytical Services LLC (U.S.)
  • Intertek Group PLC (UK)
  • Plexus Corp. (U.S.)
  • IQVIA Inc. (U.S.)
  • North American Science Associates LLC (U.S.)
  • Charles River Laboratories (U.S.)
  • West Pharmaceutical Services Inc. (U.S.)
  • WuXi AppTec (China)
  • TE Connectivity (Switzerland)
  • Freyr Solutions (Singapore)
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Medical Device Outsourcing Market Size, Share & Trends Analysis Report by Service (Regulatory Affairs Services, Product Design and Development Services, Contract Manufacturing, Quality Assurance, Product Upgrade Services, Product Testing & Sterilization Services, Product Implementation Services, Product Maintenance Services) by Application (Cardiology, Orthopedic, Ophthalmic, IVD, Diagnostic Imaging, Drug Delivery, Dental, Endoscopy, Diabetes Care, General and Plastic Surgery, Other Applications) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2017 - 2022) & Forecast (2023 - 2030)